“…1185 Therefore, the new "wonder drugs" were found to be unprofitable. 1186 Furthermore, this could make the companies hesitate to or not invest in R&D. 1187 Competitive pressure could further result in socially wasteful over-investment in R&D or induce defensive investment by those who try to strengthen their bargaining position in the field. 1188 In addition, "more competition" may also involve social costs, such as duplication of entry costs, inefficient production, multiplied investments in the same products, and the like.…”